PathAI Adds MET Predict to AISight for NSCLC Assessments
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
